CTLA4 and cancer: Immune checkpoints such as cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), programmed cell death protein-1 (PD-1), and the associated PD-1 ligand (PD-L1) have proven effective targets in the treatment of cancer.